| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Published online before print May 5, 2008
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
From the Departments of Pathology and Genetics, Yale University School of Medicine, New Haven, Connecticut
@ To whom correspondence should be addressed. E-mail: gerald.shadel{at}yale.edu.
 |
Abstract |
|---|
Mitochondria are central players in cellular energy metabolism and, consequently, defects in their function result in many characterized metabolic diseases. Critical for their function is mitochondrial DNA (mtDNA), which encodes subunits of the oxidative phosphorylation complexes essential for cellular respiration and ATP production. Expression, replication, and maintenance of mtDNA require factors encoded by nuclear genes. These include not only the primary machinery involved (eg, transcription and replication components) but also those in signaling pathways that mediate or sense alterations in mitochondrial function in accord with changing cellular needs or environmental conditions. Mutations in these contribute to human disease pathology by mechanisms that are being revealed at an unprecedented rate. As I will discuss herein, the basic protein machinery required for transcription initiation in human mitochondria has been elucidated after the discovery of two multifunctional mitochondrial transcription factors, h-mtTFB1 and h-mtTFB2, that are also rRNA methyltransferases. In addition, involvement of the ataxia-telangiectasia mutated (ATM) and target of rapamycin (TOR) signaling pathways in regulating mitochondrial homeostasis and gene expression has also recently been uncovered. These advancements embody the current mitochondrial research landscape, which can be described as exploding with discoveries of previously unanticipated roles for mitochondria in human disease and aging.
This article has been cited by other articles:
 |
|
 |
|
  V. Aksenov, J. Long, S. Lokuge, J. A Foster, J. Liu, and C D. Rollo Dietary amelioration of locomotor, neurotransmitter and mitochondrial aging Exp Biol Med, January 1, 2010; 235(1): 66 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Radulovic, E. Crane, M. Crawford, J. Godovac-Zimmermann, and V. P. C. C. Yu CKS Proteins Protect Mitochondrial Genome Integrity by Interacting with Mitochondrial Single-stranded DNA-binding Protein Mol. Cell. Proteomics, January 1, 2010; 9(1): 145 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Park, P.-y. Wang, T. Matsumoto, H. J. Sung, W. Ma, J. W. Choi, S. A. Anderson, S. C. Leary, R. S. Balaban, J.-G. Kang, et al. p53 Improves Aerobic Exercise Capacity and Augments Skeletal Muscle Mitochondrial DNA Content Circ. Res., September 25, 2009; 105(7): 705 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cotney, S. E. McKay, and G. S. Shadel Elucidation of separate, but collaborative functions of the rRNA methyltransferase-related human mitochondrial transcription factors B1 and B2 in mitochondrial biogenesis reveals new insight into maternally inherited deafness Hum. Mol. Genet., July 15, 2009; 18(14): 2670 - 2682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Gangelhoff, P. S. Mungalachetty, J. C. Nix, and M. E. A. Churchill Structural analysis and DNA binding of the HMG domains of the human mitochondrial transcription factor A Nucleic Acids Res., June 1, 2009; 37(10): 3153 - 3164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mitsuishi, K. Miyashita, A. Muraki, and H. Itoh Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycemic Control Diabetes, March 1, 2009; 58(3): 710 - 717. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
